Blockchain’s HealthSapiens Works The Telemedicine Sector With ICO Plans

News | August 15, 2018 By:

HealthSapiens is an online database of physicians working outside of the traditional healthcare system. Boasting a network of more than a thousand board-certified physicians and a membership of 22,000 people, the network platform provides unlimited access to medical services anywhere, 24 hours a day, 7 days a week. In doing so, they’ve made it possible for patients to receive necessary care without the need for cumbersome intermediaries like insurance companies or government bureaucracies.

The current HealthSapiens platform includes a client-facing, browser-based app for managing healthcare, interacting with physicians or patients, scheduling appointments, and saving medical records that have been manually collected by patients from various legacy systems. When the blockchain version launches with the DOC token, payments in DOC and other transactions will occur automatically.

Physician outcomes—based on accuracy—will be peer-reviewed and stored on the blockchain for an immutable record of performance that further leads to trust and good outcomes. Karim Babay, chairman and CEO, talked with Block Tribune about the project.

BLOCK TRIBUNE: Explain how this works. I have an ache in my side. What do I do to find a doctor?

KARIM BABAY: Currently, with our HealthSapiens 1.0 product (currently in operation):

1. Buy a HealthSapiens subscription through our website
2. Call our toll-free number (888-572-7436) or log onto our secure web portal, describe your symptoms
3. A physician will review your symptoms and follow up to diagnose and treat you
4. No additional payment necessary

With HealthSapiens 2.0, powered by blockchain (currently in development):

1. Buy HealthSapiens “DOC” tokens at an exchange (if you don’t have them already)
2. Log onto our system, describe your symptoms, choose a doctor you’re comfortable with (based on ratings, availability, etc)
3. Physician will review your symptoms and follow up to diagnose and treat you (this could include in-person visits, as needed)
4. Pay tokens for services rendered

BLOCK TRIBUNE: These are physicians who have been working in telemedicine since 2013?  What are they using now?

KARIM BABAY: They are currently using our HealthSapiens 1.0 platform, serving over 1000 board-certified physicians and over 22,000 patient-members.

BLOCK TRIBUNE: No insurance companies or government interference. The only oversight comes from peers?  Have they flagged anyone for malpractice?

KARIM BABAY: The HealthSapiens system is a peer-to-peer (P2P) networks to create a decentralized platform for physicians and patients to interact together, render payment, obtain peer reviews, and gain access to electronic medical records (EMRs) while still complying with global privacy and safety requirements. Patient outcomes, defined as outcomes that are both accurate and lead to the best solution, will be peer-reviewed and the data and stats will be irrevocably recorded on the blockchain. The patient names and details will be anonymous and each physician will have a rating based on their peer-review statistics. This transparency of outcomes will lead to higher quality care as bad actors are weeded out and patients can choose the best doctors to work with

BLOCK TRIBUNE: What are “physician outcomes.”  Please define

KARIM BABAY: These are the outcomes after diagnosis/care is provided to the patient.

BLOCK TRIBUNE: How will you determine the value of sharing the EMRs with researchers?  Will every record hold equal value?

KARIM BABAY: The EMR data belongs to the patient and the market will dictate its value. Our technology will enable the patients to take control of their and be able to share it with whomever they want, and possibly monetize it.

BLOCK TRIBUNE: What are your ICO details?

KARIM BABAY: STO as SAFTE. Security token with option to convert in equity with royalty value to holders.

BLOCK TRIBUNE: What is the status of your MIT partnership?  Any major medical alliances?

KARIM BABAY: We will work with MIT to co-develop part of the technology (we hold the patent on 17 claims) once we raise the capital